Investment
Features
FeesSafety
Academy
More
Pluang+

Canary Gold to present exploration progress at Muskoka Capital Event with key investor meetings.

Market News
23 Sep 2026
TheNewswire
View Source
Bullish
Canary Gold to present exploration progress at Muskoka Capital Event with key investor meetings.

Canary Gold Corp. will participate in the Muskoka Capital Event from September 25-27, 2026, showcasing its gold exploration projects in Brazil's Madeira River region. The company aims to engage institutional and high-net-worth investors through 18 scheduled meetings, highlighting recent geological findings including visible gold grains in samples. This event supports Canary Gold's strategy to advance exploration via staged technical validation, including further testing and proposed sonic drilling. While promising, no mineral resource or economic viability has yet been established, and further work depends on funding and permits.

Canary Gold's participation in the Muskoka Capital Event is noted here with Pluang's Basic Materials sector data as context. Of 38 priced US Basic Materials stocks on Pluang, 10 rose and 28 fell. Notable movers include NEM at USD 121.86 with a 4.24% decline, MP at USD 48.88 down 4.23%, and TECK at USD 66.00 down 4.18%, as of Sep 23, 2026 21:22 WIB.

More News

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

GE Aerospace stock could rise 35% as analysts highlight strong backlog and new engine orders.

Jefferies analysts set a new price target of $435 for General Electric Aerospace, implying a 35% upside from its current price of around $321. GE Aerospace's strong position is supported by a $170 billion commercial services backlog and 80,000 aircra...

Analyst Insights
Bullish
1 hour ago
BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas cuts PepsiCo price target to $161, citing demand challenges but keeps Outperform rating.

BNP Paribas lowered its price target for PepsiCo from $183 to $161 on September 23, 2026, due to ongoing demand challenges in North America. Despite the cut, the firm maintained an Outperform rating, indicating confidence in the stock's potential. Th...

Analyst Insights
Bearish
2 hours ago
Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
2 hours ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
2 hours ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App